Fulcrum Therapeutics, Inc. (FULC) Stock News & Chart | StockAdder

(FULC)

Fulcrum Therapeutics, Inc.

Stock chart and latest news for Fulcrum Therapeutics, Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

Fulcrum Therapeutics, Inc. News

PRO

Fulcrum Therapeutics (FULC) Is Up 31.6% After $150M Stock Offering Following Positive Pociredir Data

Dec 9, 2025 MSN

Truist Securities Initiates Coverage of Fulcrum Therapeutics (FULC) with Buy Recommendation

Apr 12, 2026 Stock Titan

Vanguard entities disaggregate Fulcrum holdings (FULC) after internal realignment

Mar 26, 2026 Gotrade

Fulcrum Therapeutics, Inc. Common Stock (FULC) Stock Price Today & Analysis

Jan 13, 2026 Zacks Investment Research

Wall Street Analysts Think Fulcrum Therapeutics (FULC) Could Surge 58.47%: Read This Before Placing a Bet

Dec 30, 2025 Investing.com

Fulcrum Therapeutics stock falls after pricing $175 million public offering

Dec 10, 2025 Benzinga

What's Going On With Fulcrum Therapeutics Stock Tuesday? - Fulcrum Therapeutics (NASDAQ:FULC)

Feb 24, 2026 Quiver Quantitative

FULCRUM THERAPEUTICS ($FULC) Releases Q4 2025 Earnings

Feb 24, 2026 simplywall.st

Fulcrum Therapeutics (FULC): Valuation Check After PIONEER Trial Success and Follow-On Offering

Dec 9, 2025 Stock Titan

Sickle cell drug from Fulcrum lifts fetal hemoglobin 12.2% in early trial data

Feb 24, 2026 Investing.com

Fulcrum Therapeutics stock tumbles despite trial results

Feb 24, 2026 Benzinga

Fulcrum Therapeutics Stock Rally Ignited By Promising Sickle Cell Results